Skip to main content
Liz Caldon

Associate Professor Liz Caldon

Laboratory Head
Replication and Genome Stability Lab

Associate Professor Liz Caldon runs a basic and translational research program on estrogen receptor positive (ER+) breast cancer, basal-like breast cancers and ovarian cancers. She is Head of the Replication and Genome Stability Group at the Garvan Institute of Medical Research. Her group has built models of hormone therapy and CDK4-6 inhibitor resistance to understand the evolution of ER+ breast cancers as they become refractory to standard of care therapies. Specific interests of her group are the understanding of tumour cell evolution through single cell modelling, cell cycle-based therapies, therapy repurposing, and the development of targeted approaches in therapy resistant disease.

Liz is a Cancer Institute NSW Fellow, and a recipient of the Mavis Robertson fellowship from the NBCF. She is an Associate Editor for the journals Oncogenesis and Endocrine Oncology.


  • 2021Cancer Institute NSW Fellowship
  • 2021Mavis Robertson NBCF Fellowship
  • 2018The Ridley Ken Davies Award
  • 2017Heliflite Young Explorer Award
  • 2017National Breast Cancer Foundation Career Development Fellowship
  • 2015CHAMP Private Equity Young Pioneer Award
  • 2014Cancer Institute Career Development Fellowship
  • 2013“Best Translational Research Presentation” - Lowy Cancer Symposium - UNSW - Sydney - Australia
  • 2013Cure Cancer Conference and Professional Development Grant
  • 2011Cure Cancer Australia Postdoctoral Fellowship
  • 2011National Breast Cancer Foundation Postdoctoral Fellowship
  • 2010Young Garvan Fellowship
  • 2005Cancer Institute NSW Scholar
  • 2004Beth Yarrow Scholarship
  • 2003LH Ainsworth Scholarship in Cancer Research
  • 2002Connaught Graduate Fellowship - University of Toronto

Selected publications

See all publications